{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:27:30Z","timestamp":1772854050801,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009881","name":"Juvenile Diabetes Research Foundation Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013528","name":"Diabetes Canada","doi-asserted-by":"publisher","award":["OG-3-14-4500-RR"],"award-info":[{"award-number":["OG-3-14-4500-RR"]}],"id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019518","name":"Eli Lilly Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jcjd.2023.04.013","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T20:26:43Z","timestamp":1682195203000},"page":"445-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes Using Oral Carbohydrates During Automated Insulin Delivery With and Without Glucagon"],"prefix":"10.1016","volume":"47","author":[{"given":"Nadine","family":"Taleb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2506-6562","authenticated-orcid":false,"given":"Virginie","family":"Messier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2023.04.013_bib1","doi-asserted-by":"crossref","unstructured":"Diabetes Canada Clinical Practice Guidelines Expert Committee, Yale JF, Paty B, Senior PA. Hypoglycemia. Can J Diabetes 2018;42(Suppl. 1):S104\u2013S108.","DOI":"10.1016\/j.jcjd.2017.10.010"},{"key":"10.1016\/j.jcjd.2023.04.013_bib2","series-title":"Encyclopedia of endocrine diseases","first-page":"245","article-title":"Insulin pumps and artificial pancreas","author":"Taleb","year":"2019"},{"key":"10.1016\/j.jcjd.2023.04.013_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2337\/ds18-0094","article-title":"Single-hormone artificial pancreas use in diabetes: Clinical efficacy and remaining challenges","volume":"32","author":"Taleb","year":"2019","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.jcjd.2023.04.013_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","article-title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: A systematic review and meta-analysis of outpatient randomised controlled trials","volume":"5","author":"Weisman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcjd.2023.04.013_bib5","doi-asserted-by":"crossref","first-page":"154953","DOI":"10.1016\/j.metabol.2021.154953","article-title":"Recent advances in closed-loop insulin delivery","volume":"127","author":"Ware","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.jcjd.2023.04.013_bib6","doi-asserted-by":"crossref","first-page":"k1310","DOI":"10.1136\/bmj.k1310","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis","volume":"361","author":"Bekiari","year":"2018","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2023.04.013_bib7","first-page":"S61","article-title":"6. Glycemic targets: Standards of medical care in diabetes---2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.04.013_bib8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcjd.2016.05.008","article-title":"Treatment of hypoglycemia in adult patients with type 1 diabetes: An observational study","volume":"40","author":"Savard","year":"2016","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2023.04.013_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00592-017-1085-8","article-title":"Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: Are current recommendations effective?","volume":"55","author":"Gingras","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jcjd.2023.04.013_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S2213-8587(21)00267-9","article-title":"Open-source automated insulin delivery: International consensus statement and practical guidance for health-care professionals","volume":"10","author":"Braune","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcjd.2023.04.013_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/dia.2016.0349","article-title":"\"Let the algorithm do the work\": Reduction of hypoglycemia using sensor-augmented pump therapy with predictive insulin suspension (SmartGuard) in pediatric type 1 diabetes patients","volume":"19","author":"Biester","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2023.04.013_bib12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/dia.2019.0105","article-title":"A\u00a0clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm","volume":"21","author":"Messer","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2023.04.013_bib13","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1111\/dom.13304","article-title":"Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetes","volume":"20","author":"Ruan","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2023.04.013_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(14)70226-8","article-title":"Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: An open-label randomised controlled crossover trial","volume":"3","author":"Haidar","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcjd.2023.04.013_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1503\/cmaj.121265","article-title":"Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: A randomized crossover controlled trial","volume":"185","author":"Haidar","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.jcjd.2023.04.013_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/dia.2017.0353","article-title":"Overnight glucose control with dual- and single-hormone artificial pancreas in type 1 diabetes with hypoglycemia unawareness: A randomized controlled trial","volume":"20","author":"Abitbol","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2023.04.013_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabet.2015.05.001","article-title":"Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial","volume":"42","author":"Gingras","year":"2016","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcjd.2023.04.013_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.diabet.2013.12.001","article-title":"Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus","volume":"40","author":"Haidar","year":"2014","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcjd.2023.04.013_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1089\/dia.2020.0619","article-title":"Predictive low-glucose suspend necessitates less carbohydrate supplementation to rescue hypoglycemia: Need to revisit current hypoglycemia treatment guidelines","volume":"23","author":"Pinsker","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2023.04.013_bib20","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1001\/jama.1984.03350240024032","article-title":"Treatment of insulin reactions in diabetics","volume":"252","author":"Brodows","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2023.04.013_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archinte.1990.00390150083016","article-title":"The search for an optimized treatment of hypoglycemia. Carbohydrates in tablets, solutin, or gel for the correction of insulin reactions","volume":"150","author":"Slama","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcjd.2023.04.013_bib22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/dme.13379","article-title":"Emergency treatment of hypoglycaemia: A guideline and evidence review","volume":"34","author":"Villani","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2023.04.013_bib23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1177\/193229681000400603","article-title":"Factors influencing the effectiveness of glucagon for preventing hypoglycemia","volume":"4","author":"Castle","year":"2010","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.jcjd.2023.04.013_bib24","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1177\/193229681000400602","article-title":"Efficacy determinants of subcutaneous microdose glucagon during closed-loop control","volume":"4","author":"Russell","year":"2010","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.jcjd.2023.04.013_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/dom.12789","article-title":"Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use","volume":"19","author":"Taleb","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2023.04.013_bib26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/dia.2018.0400","article-title":"Changes in accuracy of continuous glucose monitoring using dexcom g4 platinum over the course of moderate intensity aerobic exercise in type 1 diabetes","volume":"21","author":"Larose","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2023.04.013_bib27","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fendo.2018.00818","article-title":"The benefits and limits of technological advances in glucose management around physical activity in patients type 1 diabetes","volume":"9","author":"Tagougui","year":"2018","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267123000941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267123000941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:38:56Z","timestamp":1761493136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267123000941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1499267123000941"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2023.04.013","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes Using Oral Carbohydrates During Automated Insulin Delivery With and Without Glucagon","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2023.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}